Literature DB >> 11255088

Vascular and perfusion imaging using encapsulated laser-polarized helium.

V Callot1, E Canet, J Brochot, Y Berthezène, M Viallon, H Humblot, A Briguet, H Tournier, Y Crémillieux.   

Abstract

In this work, the use of hyperpolarized (HP) 3He for in vivo intravascular imaging on animal is reported. To overcome the problem of the low solubility of helium in blood, we propose an approach based on helium encapsulation in lipid-based carrier agents. The mean diameter of the 3He microbubbles, measured equal to 3.0+/-0.2 microm, makes it possible to conduct in vivo studies. In vitro spectroscopy yielded a longitudinal relaxation time T(1) equal to 90 s and an apparent transverse relaxation time T(2)(*) of 4.5 ms. Angiographic imaging (venous and cardiac cavity visualization), as well as lung perfusion imaging, were demonstrated in rats using intravenous injections of microbubble suspensions. Suitable signal and spatial resolution were achieved. The potential of this technique for lung perfusion assessment was assessed using an experimental animal embolism model. Lung perfusion defects and recovery towards a normal perfusion state were visualized. This study was completed with the demonstration of a new ventilation-perfusion lung exploration method based entirely on HP 3He.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255088     DOI: 10.1007/bf02678269

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  17 in total

1.  Hyperpolarized 3He microspheres as a novel vascular signal source for MRI.

Authors:  M S Chawla; X J Chen; G P Cofer; L W Hedlund; M B Kerby; T B Ottoboni; G A Johnson
Journal:  Magn Reson Med       Date:  2000-03       Impact factor: 4.668

2.  Magnetic resonance angiography with hyperpolarized 129Xe dissolved in a lipid emulsion.

Authors:  H E Möller; M S Chawla; X J Chen; B Driehuys; L W Hedlund; C T Wheeler; G A Johnson
Journal:  Magn Reson Med       Date:  1999-05       Impact factor: 4.668

3.  Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging.

Authors:  D R Morel; I Schwieger; L Hohn; J Terrettaz; J B Llull; Y A Cornioley; M Schneider
Journal:  Invest Radiol       Date:  2000-01       Impact factor: 6.016

4.  Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40.

Authors:  Y Berthezène; V Vexler; D C Price; J Wisner-Dupon; M E Moseley; K P Aicher; R C Brasch
Journal:  Invest Radiol       Date:  1992-05       Impact factor: 6.016

5.  Distribution and dynamics of laser-polarized (129)Xe magnetization in vivo.

Authors:  S D Swanson; M S Rosen; K P Coulter; R C Welsh; T E Chupp
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

6.  Biological magnetic resonance imaging using laser-polarized 129Xe.

Authors:  M S Albert; G D Cates; B Driehuys; W Happer; B Saam; C S Springer; A Wishnia
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

7.  Solubility of inert gases in biological fluids and tissues: a review.

Authors:  P K Weathersby; L D Homer
Journal:  Undersea Biomed Res       Date:  1980-12

8.  A combined 1H perfusion/3He ventilation NMR study in rat lungs.

Authors:  Y Crémillieux; Y Berthezène; H Humblot; M Viallon; E Canet; M Bourgeois; T Albert; W Heil; A Briguet
Journal:  Magn Reson Med       Date:  1999-04       Impact factor: 4.668

9.  Brain MRI with laser-polarized 129Xe.

Authors:  S D Swanson; M S Rosen; B W Agranoff; K P Coulter; R C Welsh; T E Chupp
Journal:  Magn Reson Med       Date:  1997-11       Impact factor: 4.668

10.  Characteristics of SonoVuetrade mark.

Authors:  Michel Schneider
Journal:  Echocardiography       Date:  1999-10       Impact factor: 1.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.